The Arc Gene Confers Genetic Susceptibility to Alzheimer’s Disease in Han Chinese

Molecular Neurobiology

Volumn 55, Issue 2, 2018, Pages 1217-1226

  Bi, Rui ^a   Kong, Li Li ^a,b   Xu, Min ^a,c   Li, Guo Dong ^a,c   Zhang, Deng Feng ^a   Li, Tao ^d   Fang, Yiru ^e   Zhang, Chen ^e   Zhang, Buchang ^b   Yao, Yong Gang ^a,f  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b ANHUI UNIVERSITY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^d SICHUAN UNIVERSITY   (China)

^e SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^f Shenzhen Fundamental Research Institutions   (China)

Author keywords

Alzheimer s disease; Arc gene; Genetic susceptibility; Han Chinese

Indexed keywords

BIOLOGICAL MARKER; ACTIVITY REGULATED CYTOSKELETAL-ASSOCIATED PROTEIN; CYTOSKELETON PROTEIN; NERVE PROTEIN;

3' UNTRANSLATED REGION; ADULT; ALZHEIMER DISEASE; ARC GENE; ARTICLE; CASE CONTROL STUDY; COGNITION; CONTROLLED STUDY; EXON; GENE EXPRESSION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAN CHINESE; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; MENTAL PERFORMANCE; ONSET AGE; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED;

AGED; ALLELES; ALZHEIMER DISEASE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; CYTOSKELETAL PROTEINS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 85009881965     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-017-0397-6     Document Type: Article

References (59)

1. Querfurth HW, LaFerla FM (2010) Alzheimer’s disease. N Engl J Med 362(4):329–344
2. Hardy JA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256(5054):184–185
3. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297(5580):353–356
4. Bertram L, Lill CM, Tanzi RE (2010) The genetics of Alzheimer disease: back to the future. Neuron 68(2):270–281
5. Karch CM, Goate AM (2015) Alzheimer’s disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry 77(1):43–51
6. De Strooper B, Karran E (2016) The cellular phase of Alzheimer’s disease. Cell 164(4):603–615
7. Sevigny J, Chiao P, Bussiere T, Weinreb PH, Williams L, Maier M et al (2016) The antibody aducanumab reduces Abeta plaques in Alzheimer’s disease. Nature 537(7618):50–56
8. Kerrigan TL, Randall AD (2013) A new player in the “synaptopathy” of Alzheimer’s disease-arc/arg 3.1. Front Neurol 4:9
9. Bramham CR, Worley PF, Moore MJ, Guzowski JF (2008) The immediate early gene arc/arg3.1: regulation, mechanisms, and function. J Neurosci 28(46):11760–11767
10. Lyford GL, Yamagata K, Kaufmann WE, Barnes CA, Sanders LK, Copeland NG et al (1995) Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 14(2):433–445
11. Ying SW, Futter M, Rosenblum K, Webber MJ, Hunt SP, Bliss TV et al (2002) Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: requirement for ERK activation coupled to CREB and upregulation of arc synthesis. J Neurosci 22(5):1532–1540
12. Plath N, Ohana O, Dammermann B, Errington ML, Schmitz D, Gross C et al (2006) Arc/Arg3.1 is essential for the consolidation of synaptic plasticity and memories. Neuron 52(3):437–444
13. Waung MW, Pfeiffer BE, Nosyreva ED, Ronesi JA, Huber KM (2008) Rapid translation of arc/Arg3.1 selectively mediates mGluR-dependent LTD through persistent increases in AMPAR endocytosis rate. Neuron 59(1):84–97
14. Bramham CR, Alme MN, Bittins M, Kuipers SD, Nair RR, Pai B et al (2010) The Arc of synaptic memory. Exp Brain Res 200(2):125–140
15. Guzowski JF, Lyford GL, Stevenson GD, Houston FP, McGaugh JL, Worley PF et al (2000) Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of long-term memory. J Neurosci 20(11):3993–4001
16. Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL et al (2004) Synaptic targeting by Alzheimer’s-related amyloid beta oligomers. J Neurosci 24(45):10191–10200
17. Wu J, Petralia RS, Kurushima H, Patel H, Jung MY, Volk L et al (2011) Arc/Arg3.1 regulates an endosomal pathway essential for activity-dependent beta-amyloid generation. Cell 147(3):615–628
18. Landgren S, von Otter M, Palmer MS, Zetterstrom C, Nilsson S, Skoog I et al (2012) A novel ARC gene polymorphism is associated with reduced risk of Alzheimer’s disease. J Neural Transm (Vienna) 119(7):833–842
19. Bi R, Zhao L, Zhang C, Lu W, Feng JQ, Wang Y et al (2014) No association of the LRRK2 genetic variants with Alzheimer’s disease in Han Chinese individuals. Neurobiol Aging 35(2):444. e5–9
20. Wang HZ, Bi R, Hu QX, Xiang Q, Zhang C, Zhang DF et al (2016) Validating GWAS-identified risk loci for Alzheimer’s disease in Han Chinese populations. Mol Neurobiol 53(1):379–390
21. Wang HZ, Bi R, Zhang DF, Li GD, Ma XH, Fang Y et al (2016) Neprilysin confers genetic susceptibility to Alzheimer’s disease in Han Chinese. Mol Neurobiol 53(7):4883–4892
22. Zhang DF, Li J, Wu H, Cui Y, Bi R, Zhou HJ et al (2016) CFH variants affect structural and functional brain changes and genetic risk of Alzheimer’s disease. Neuropsychopharmacology 41(4):1034–1045
23. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34(7):939–944
24. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263–265
25. International HapMap Consortium (2003) The International HapMap Project. Nature 426(6968):789–796
26. Zhang DF, Fan Y, Wang D, Bi R, Zhang C, Fang Y et al (2015) PLD3 in Alzheimer’s disease: a modest effect as revealed by updated association and expression analyses. Mol Neurobiol 53(6):4034–4045
27. Wang D, Li GD, Zhang DF, Xu L, Li XA, Yu XF et al (2016) Genetic variants of the MAVS, MITA and MFN2 genes are not associated with leprosy in Han Chinese from Southwest China. Infect Genet Evol 45:105–110
28. Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25(14):1754–1760
29. Li H (2011) A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data. Bioinformatics 27(21):2987–2993
30. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N et al (2009) The sequence alignment/map format and SAMtools. Bioinformatics 25(16):2078–2079
31. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C et al (2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43(5):491–498
32. Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO et al (2015) A global reference for human genetic variation. Nature 526(7571):68–74
33. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE et al (2012) An integrated map of genetic variation from 1,092 human genomes. Nature 491(7422):56–65
34. Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T et al (2016) Analysis of protein-coding genetic variation in 60,706 humans. Nature 536(7616):285–291
35. Kircher M, Witten DM, Jain P, O’Roak BJ, Cooper GM, Shendure J (2014) A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 46(3):310–315
36. Ramasamy A, Trabzuni D, Guelfi S, Varghese V, Smith C, Walker R et al (2014) Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat Neurosci 17(10):1418–1428
37. Kallberg M, Wang H, Wang S, Peng J, Wang Z, Lu H et al (2012) Template-based protein structure modeling using the RaptorX web server. Nat Protoc 7(8):1511–1522
38. Gauderman WJ (2002) Sample size requirements for matched case-control studies of gene-environment interaction. Stat Med 21(1):35–50
39. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559–575
40. Simpson JE, Ince PG, Shaw PJ, Heath PR, Raman R, Garwood CJ et al (2011) Microarray analysis of the astrocyte transcriptome in the aging brain: relationship to Alzheimer’s pathology and APOE genotype. Neurobiol Aging 32(10):1795–1807
41. Durrenberger PF, Fernando FS, Magliozzi R, Kashefi SN, Bonnert TP, Ferrer I et al (2012) Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe study. Acta Neuropathol 124(6):893–903
42. Berson A, Barbash S, Shaltiel G, Goll Y, Hanin G, Greenberg DS et al (2012) Cholinergic-associated loss of hnRNP-A/B in Alzheimer’s disease impairs cortical splicing and cognitive function in mice. EMBO Mol Med 4(8):730–742
43. Berchtold NC, Cribbs DH, Coleman PD, Rogers J, Head E, Kim R et al (2008) Gene expression changes in the course of normal brain aging are sexually dimorphic. Proc Natl Acad Sci U S A 105(40):15605–15610
44. Liang WS, Dunckley T, Beach TG, Grover A, Mastroeni D, Walker DG et al (2007) Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain. Physiol Genomics 28(3):311–322
45. Taminau J, Meganck S, Lazar C, Steenhoff D, Coletta A, Molter C et al (2012) Unlocking the potential of publicly available microarray data using inSilicoDb and inSilicoMerging R/Bioconductor packages. BMC Bioinformatics 13:335
46. Weiner MW, Aisen PS, Jack CR Jr, Jagust WJ, Trojanowski JQ, Shaw L et al (2010) The Alzheimer’s disease neuroimaging initiative: progress report and future plans. Alzheimers Dement 6(3):202–211. e7
47. Yao YG, Kong QP, Bandelt HJ, Kivisild T, Zhang YP (2002) Phylogeographic differentiation of mitochondrial DNA in Han Chinese. Am J Hum Genet 70(3):635–651
48. Shepherd JD, Bear MF (2011) New views of Arc, a master regulator of synaptic plasticity. Nat Neurosci 14(3):279–284
49. Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P et al (2014) De novo mutations in schizophrenia implicate synaptic networks. Nature 506(7487):179–184
50. Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P et al (2014) A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506(7487):185–190
51. Elizalde N, Pastor PM, Garcia-Garcia AL, Serres F, Venzala E, Huarte J et al (2010) Regulation of markers of synaptic function in mouse models of depression: chronic mild stress and decreased expression of VGLUT1. J Neurochem 114(5):1302–1314
52. Myrum C, Giddaluru S, Jacobsen K, Espeseth T, Nyberg L, Lundervold AJ et al (2015) Common variants in the ARC gene are not associated with cognitive abilities. Brain Behav 5(10):e00376
53. Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet 45(12):1452–1458
54. Wegenast-Braun BM, Fulgencio Maisch A, Eicke D, Radde R, Herzig MC, Staufenbiel M et al (2009) Independent effects of intra- and extracellular Abeta on learning-related gene expression. Am J Pathol 175(1):271–282
55. Alhowikan AM (2016) Activity-regulated cytoskeleton-associated protein dysfunction may contribute to memory disorder and earlier detection of autism spectrum disorders. Med Princ Pract 25(4):350–354
56. Shepherd JD, Rumbaugh G, Wu J, Chowdhury S, Plath N, Kuhl D et al (2006) Arc/Arg3.1 mediates homeostatic synaptic scaling of AMPA receptors. Neuron 52(3):475–484
57. Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L (2006) Association between CSF biomarkers and incipient Alzheimer’s disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 5(3):228–234
58. Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC et al (2009) Cerebrospinal fluid biomarker signature in Alzheimer’s disease neuroimaging initiative subjects. Ann Neurol 65(4):403–413
59. Blennow K, Dubois B, Fagan AM, Lewczuk P, de Leon MJ, Hampel H (2015) Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer’s disease. Alzheimers Dement 11(1):58–69